Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The Hippo signalling pathway plays important roles in animal development, physiology and tumorigenesis. Understanding how the activity of this pathway is regulated by the cellular microenvironment remains a major challenge. Here we elucidate a molecular mechanism by which hypoxia deactivates Hippo signalling. We demonstrate that the E3 ubiquitin ligase SIAH2 stimulates YAP by destabilizing LATS2, a critical component of the Hippo pathway, in response to hypoxia. Loss of SIAH2 suppresses tumorigenesis in a LATS2-dependent manner in a xenograft mouse model. We further show that YAP complexes with HIF1α and is essential for HIF1α stability and function in tumours in vivo. LATS2 is downregulated in human breast tumours and negatively correlates with SIAH2 expression levels, indicating that the SIAH2-LATS2 pathway may have a role in human cancer. Our data uncover oxygen availability as a microenvironment signal for the Hippo pathway and have implications for understanding the regulation of Hippo signalling in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Yap directly interacts with and stabilises Hif1 α (88).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [88]
In the citing paper
“For example, hypoxia activates the E3 ligase Siah2, which leads to the degradation of Lats2. This results in a decreased level of Yap phosphorylation, increasing the activity of Yap in the nucleus (88).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [88]
In the citing paper
“Endurance exercise-associated signals linked to YAP/TAZ”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as Ma et al Nature Cell Biol (2015)
In the citing paper
“Remarkably, another study reported that the activity of YAP (Yes-associated protein), which is a homolog of TAZ, was induced by HIF-1α-dependent expression of SIAH2, which is a homolog of SIAH1, leading to LATS2 degradation [83].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [83]
Citations
Cites
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Self-citationThe Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Self-citationThe Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
The Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
“Hypoxia inhibits the Hippo pathway, leading to YAP/TAZ activation (140).”
BackgroundHippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“, 2015b), hypoxia (Ma et al., 2015), oxidative stress (Lehtinen et al.”
BackgroundThe Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Self-citationYAP and TAZ: a nexus for Hippo signaling and beyond
Hansen, C. G., Moroishi, T., & Guan, K.-L. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.05.002 · Cited by 574
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Semenza, G. L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.036 · Cited by 535
Ubiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.105 · Cited by 489
Interplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K.-L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 472
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Wei, X., Chen, Y., Jiang, X., Peng, M., Liu, Y., Mo, Y., Ren, D., Hua, Y., Yu, B., Zhou, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01288-1 · Cited by 463
Self-citationTumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
Lee, C.-K., Jeong, S.-H., Jang, C., Bae, H., Kim, Y. H., Park, I., Kim, S. K., & Koh, G. Y. (2019) · Science · doi:10.1126/science.aav0173 · Cited by 400
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration
Wang, J., Liu, S., Heallen, T., & Martin, J. F. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0063-3 · Cited by 380
The Hippo pathway in intestinal regeneration and disease
Hong, A. W., Meng, Z., & Guan, K.-L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.59 · Cited by 326
Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
Kim, M., Kim, T., Johnson, R. L., & Lim, D.-S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.015 · Cited by 287
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Noguchi, S., Saito, A., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113674 · Cited by 277
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Furth, N., & Aylon, Y. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.99 · Cited by 260
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Thompson, B. J. (2020) · BioEssays · doi:10.1002/bies.201900162 · Cited by 259
Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila
Liu, B., Zheng, Y., Yin, F., Yu, J., Silverman, N., & Pan, D. (2016) · Cell · doi:10.1016/j.cell.2015.12.029 · Cited by 249
Qiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Zhang, X., Li, Y., Ma, Y., Yang, L., Wang, T., Meng, X., Zong, Z., Sun, X., Hua, X., & Li, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0892-2 · Cited by 234
RetractedA combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Pobbati, A. V., & Hong, W. (2020) · Theranostics · doi:10.7150/thno.40889 · Cited by 222
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A., & Del Río Hernández, A. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 214
Hippo signalling in the liver: role in development, regeneration and disease
Russell, J. O., & Camargo, F. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00571-w · Cited by 207
The Hippo signaling pathway in development and regeneration
Zhong, Z., Jiao, Z., & Yu, F.-X. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113926 · Cited by 200
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park, J. H., Shin, J. E., & Park, H. W. (2018) · PubMed · doi:10.14348/molcells.2018.2242 · Cited by 193
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Sardo, F. L., Muti, P., Blandino, G., & Strano, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091913 · Cited by 179
An overview of signaling pathways regulating YAP/TAZ activity
Heng, B. C., Zhang, X., Aubel, D., Bai, Y., Li, X., Yan, W., Fussenegger, M., & Deng, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03579-8 · Cited by 161
Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network
Sun, S., & Irvine, K. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.003 · Cited by 134
Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways
Heng, B. C., Zhang, X., Aubel, D., Bai, Y., Li, X., Yan, W., Fussenegger, M., & Deng, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00735 · Cited by 143
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Sardo, F. L., Strano, S., & Blandino, G. (2018) · Cancers · doi:10.3390/cancers10050137 · Cited by 128
White, S. M., Avantaggiati, M. L., Nemazanyy, I., Poto, C. D., Yang, Y., Pende, M., Gibney, G. T., Ressom, H. W., Field, J., Atkins, M. B., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.014 · Cited by 129
A compendium of proteins that interact with HIF-1α
Semenza, G. L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.041 · Cited by 115
Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
Ma, B., Cheng, H., Gao, R., Mu, C., Chen, L., Wu, S., Chen, Q., & Zhu, Y. (2016) · Nature Communications · doi:10.1038/ncomms11123 · Cited by 111
Self-citationHeat stress activates YAP/TAZ to induce the heat shock transcriptome
Luo, M., Meng, Z., Moroishi, T., Lin, K. C., Shen, G., Mo, F., Shao, B., Wei, X., Zhang, P., Wei, Y., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00602-9 · Cited by 112
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
Kovar, H., Bierbaumer, L., & Radic-Sarikas, B. (2020) · Cells · doi:10.3390/cells9040972 · Cited by 127
GPCR-Hippo Signaling in Cancer
Luo, J., & Yu, F. (2019) · Cells · doi:10.3390/cells8050426 · Cited by 130
The ubiquitin codes in cellular stress responses
Sheng, X., Xia, Z., Yang, H., & Hu, R. (2023) · Protein & Cell · doi:10.1093/procel/pwad045 · Cited by 129
Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
Sun, X., Ding, Y., Zhan, M., Li, Y., Gao, D., Wang, G., Gao, Y., Li, Y., Wu, S., Lu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08334-7 · Cited by 99
Self-citationSivaraj, K. K., Dharmalingam, B., Mohanakrishnan, V., Jeong, H., Kato, K., Schröder, S., Adams, S., Koh, G. Y., & Adams, R. H. (2020) · eLife · doi:10.7554/elife.50770 · Cited by 94
YAP/TAZ: Molecular pathway and disease therapy
Wei, Y., Hui, V. L. Z., Chen, Y., Han, R., Han, X., & Guo, Y. (2023) · MedComm · doi:10.1002/mco2.340 · Cited by 122
Self-citationDynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
Semenza, G. L. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.09.004 · Cited by 97
NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma
Lai, R. K.-H., Xu, I. M.-J., Chiu, D. K.-C., Tse, A. P.-W., Wei, L. L., Law, C.-T., Lee, D., Wong, C.-M., Wong, M. P., Ng, I. O.-L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1987 · Cited by 91
YAP and TAZ Take Center Stage in Cancer
Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 99
The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression
Ma, B., Cheng, H., Mu, C., Geng, G., Zhao, T., Luo, Q., Ma, K., Chang, R., Liu, Q., Gao, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08618-y · Cited by 89
Self-citationToloczko, A. D., Guo, F., Yuen, H., Wen, Q., Wood, S. A., Ong, Y. S., Chan, P. Y., Shaik, A. A., Gunaratne, J., Dunne, M. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3413 · Cited by 89
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
Greenhough, A., Bagley, C., Heesom, K. J., Gurevich, D. B., Gay, D., Bond, M., Collard, T. J., Paraskeva, C., Martin, P., Sansom, O. J., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708699 · Cited by 87
TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration
Gao, Y., Yang, Y., Yuan, F., Huang, J., Xu, W., Mao, B., Yuan, Z., & Bi, W. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.83 · Cited by 96
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
Yuan, Y. J., Adam, A., Zhao, C., & Chen, H. (2021) · Cancers · doi:10.3390/cancers13040663 · Cited by 92
The Hippo signaling pathway provides novel anti-cancer drug targets
Bae, J. S., Kim, S. M., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.14306 · Cited by 96
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
Juan, W., & Hong, W. (2016) · Genes · doi:10.3390/genes7090055 · Cited by 85
New insights into the ambivalent role of YAP/TAZ in human cancers
Luo, J., Deng, L., Zou, H., Guo, Y., Tong, T., Huang, M., Ling, G., & Li, P. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02704-2 · Cited by 98
The Atypical Cadherin Fat Directly Regulates Mitochondrial Function and Metabolic State
Sing, A. D., Tsatskis, Y., Fabian, L., Hester, I., Rosenfeld, R., Serricchio, M., Yau, N., Bietenhader, M., Shanbhag, R., Jurisicova, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.036 · Cited by 88
A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs
Shue, Y. T., Drainas, A. P., Li, N. Y., Pearsall, S. M., Morgan, D., Sinnott-Armstrong, N., Hipkins, S. Q., Coles, G. L., Lim, J. S., Oro, A. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30416-2 · Cited by 86
He, M., Zhou, Z., Shah, A. A., Hong, Y., Chen, Q., & Wan, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0013-6 · Cited by 77
Self-citationThe history and regulatory mechanism of the Hippo pathway
Kim, W., & Jho, E. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.022 · Cited by 87
Raslan, A., Pham, T. X., Lee, J., Kontodimas, K., Tilston-Lünel, A., Schmottlach, J., Hong, J., Dinc, M. T., Bujor, A. M., Caporarello, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49545-x · Cited by 99
Yim, A., Koti, P. S., Bonnard, A., Marchianò, F., Dürrbaum, M., García-Pérez, C., Villaveces, J. M., Gamal, S., Cardone, G., Perocchi, F., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1128 · Cited by 77
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Xiang, L., Gilkes, D. M., Hu, H., Luo, W., Bullen, J. W., Liang, H., & Semenza, G. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4190 · Cited by 73
Dai, X.-Y., Zhuang, L.-H., Wang, D.-D., Zhou, T.-Y., Chang, L.-L., Gai, R.-H., Zhu, D.-F., Yang, B., Zhu, H., & He, Q.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.6903 · Cited by 72
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability
Kim, Y., Kim, W., Song, Y., Kim, J., Cho, K., Moon, H., Ro, S. W., Seo, E., Ryu, Y., Myung, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620306114 · Cited by 78
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Liu, Y., Lu, J., Zhang, Z., Zhu, L., Dong, S., Guo, G., Li, R., Yang, N., Yu, K., Zhong, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.396 · Cited by 72
Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF‐1α signaling
Zhang, C., Bian, M., Chen, X., Jin, H., Zhao, S., Xiang, Y., Shao, J., Chen, A., Guo, Q., Zhang, F., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26388 · Cited by 74
Emerging roles of DYRK2 in cancer
Tandon, V., de la Vega, L., & Banerjee, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.015217 · Cited by 70
Kao, S.-H., Cheng, W., Wang, Y.-T., Wu, H.-T., Yeh, H.-Y., Chen, Y., Tsai, M., & Wu, K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2376 · Cited by 69
Self-citationde Herreros, A. G., & Duñach, M. (2019) · Cells · doi:10.3390/cells8101148 · Cited by 73
Zhou, T., Zhuang, L., Hu, Y. W., Zhou, Y., Lin, W., Wang, D., Wan, Z.-Q., Chang, L.-L., Chen, Y., Ying, M., et al. (2016) · Scientific Reports · doi:10.1038/srep30483 · Cited by 68
Self-citationRegulation of the Hippo signaling pathway by ubiquitin modification
Kim, Y., & Jho, E. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.017 · Cited by 66
Regulation of Myocardial Cell Growth and Death by the Hippo Pathway
Ikeda, S., & Sadoshima, J. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0476 · Cited by 63
Zhu, C., Ji, X., Zhang, H., Zhou, Q., Cao, X., Tang, M., Si, Y., Yan, H., Li, L., Liang, T., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000392 · Cited by 64
Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
Zhao, W., Wang, M., Cai, M., Zhang, C.-H., Qiu, Y., Wang, X., Zhang, T., Zhou, H., Wang, J., Zhao, W., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110956 · Cited by 62
The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
Nguyen‐Lefebvre, A. T., Selzner, N., Wrana, J. L., & Bhat, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002284rr · Cited by 58
New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
Zhao, Y., Sheldon, M., Sun, Y., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15235497 · Cited by 68
Li, H., Li, X., Jing, X., Li, M., Ren, Y., Chen, J., Yang, C., Wu, H. K., & Guo, F. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3921 · Cited by 60
Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis
Chen, X., Stauffer, S., Chen, Y., & Dong, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.722751 · Cited by 57
Self-citationYAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 59
Tung, J.-N., Lin, P.-L., Wang, Y.-C., Wu, D., Chen, C.-Y., & Lee, H. (2017) · Oncotarget · doi:10.18632/oncotarget.23161 · Cited by 53
Targeting the Hippo pathway in heart repair
Meng, F., Xie, B., & Martin, J. F. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab291 · Cited by 56
The roles of ubiquitin modifying enzymes in neoplastic disease
Kumari, N., Jaynes, P. W., Saei, A., Iyengar, P. V., Richard, J. L. C., & Eichhorn, P. J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.002 · Cited by 52
Zhao, C., Zeng, C., Ye, S., Dai, X., He, Q., Yang, B., & Zhu, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.010 · Cited by 53
The Hippo signal transduction network for exercise physiologists
Gabriel, B. M., Hamilton, D. L., Tremblay, A. M., & Wackerhage, H. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01076.2015 · Cited by 48
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Lv, L., & Zhou, X. (2023) · MedComm · doi:10.1002/mco2.375 · Cited by 58
The Hippo pathway: Organ size control and beyond
Guo, P., Wan, S., & Guan, K. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100031 · Cited by 60
Zhu, H., Wang, D., Yuan, T., Yan, F., Zeng, C., Dai, X.-Y., Chen, Z., Chen, Y., Zhou, T., Fan, G.-H., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1548 · Cited by 44
Self-citationLiu, Y., Wang, K., Cheng, Q., Kong, D., Zhang, X., Wang, Z., Wang, Q., Xie, Q., Yan, J., Chu, J., et al. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa255 · Cited by 55
Zhou, J., Hu, M., He, M., Wang, X., Sun, D., Huang, Y., Cheng, X., Fu, J., Cai, J., Ma, T., et al. (2021) · Hepatology · doi:10.1002/hep.32015 · Cited by 44
EIF3H Orchestrates Hippo Pathway–Mediated Oncogenesis via Catalytic Control of YAP Stability
Zhou, Z., Zhou, H., Ponzoni, L., Luo, A., Zhu, R., He, M., Huang, Y., Guan, K., Bahar, İ., Liu, Z., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3718 · Cited by 43
Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
Luo, J., & Li, P. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02686-y · Cited by 44
Emerging role of Hippo signalling pathway in bladder cancer
Xia, J., Zeng, M., Zhu, H., Chen, X., Weng, Z., & Li, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13293 · Cited by 47
CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2
García-Limones, C., Lara‐Chica, M., Jiménez‐Jiménez, C., Pérez, M., Moreno, P., Muñóz, E., & Calzado, M. A. (2016) · Oncogene · doi:10.1038/onc.2015.495 · Cited by 40
Context-dependent transcriptional regulations of YAP/TAZ in cancer
Guo, Y., Luo, J., Zou, H., Liu, C., Deng, L., & Li, P. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.019 · Cited by 41
Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
Samji, P., Rajendran, M. K., Warrier, V. P., Ganesh, A., & Karunagaran, D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109858 · Cited by 42
Kim, Y., Kim, H., Park, D., & Jeoung, D. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0051 · Cited by 37
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Yuan, T., Rafizadeh, S., Azizi, Z., Lupše, B., Gorrepati, K. D. D., Awal, S., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · JCI Insight · doi:10.1172/jci.insight.86326 · Cited by 43
Functional analysis of the seven in absentia ubiquitin ligase family in tomato
Wang, W., Fan, Y.-H., Niu, X., Miao, M., Kud, J., Zhou, B., Zeng, L., Liu, Y., & Xiao, F. (2018) · Plant Cell & Environment · doi:10.1111/pce.13140 · Cited by 38
Jia, Y., Li, H., Wang, J., Wang, Y., Zhang, P., Ma, N., & Mo, S. (2019) · Oncogenesis · doi:10.1038/s41389-019-0143-1 · Cited by 38
Metadata
- Authors
- Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., Zhu, Y., Chen, Q., & Wu, S.
- Affiliations
- Nankai University (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zhu, Yushan
- Chen, Quan
- Wu, Shian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2014-12-01
- Volume
- 17
- Issue
- 1
- Pages
- 95-103
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2091267676
- Cited by
- 266
- References
- 37
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 36 · 2023: 23 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 23 · 2018: 29 · 2017: 19 · 2016: 21 · 2015: 13 · 2014: 1
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tsinghua University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- hypoxia, Hippo signaling pathway, SIAH2, E3 ubiquitin ligase, YAP, HIF-1α, carcinogenesis, protein degradation, tumor microenvironment, breast cancer, oxygen availability
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, Seven in Absentia Proteins, Animals, Breast Neoplasms, Cell Transformation, Neoplastic, Female, HeLa Cells, Humans, Mice, Nude, Neoplasm Transplantation, Nuclear Proteins, Phosphoproteins, Phosphorylation, Transcription Factors, Transplantation, Heterologous, Signal Transduction, Down-Regulation, Cell Hypoxia, Protein Serine-Threonine Kinases, Tumor Suppressor Proteins, RNA Interference, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, HEK293 Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.